Agoracom Blog Home

Posts Tagged ‘CSE’

Tech Reskilling in India a Necessity #Edtech – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 11:54 AM on Thursday, March 5th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Tech Reskilling in India a Necessity

  • Behind the AI and data analytics boom, lies the story of a massive talent gap as workforce struggles to remain employable
  • The skills’ shelf life has shortened, with technology changing exponentially over the last decade, skills that were relevant at the beginning of the career have become obsolete

By Kasmin Fernandes

While skill development gets a major chunk of CSR funding, reskilling in India isn’t a priority. Even with the third-largest developer base and a substantial tech-savvy talent pool, India lags behind its peers on major AI indicators. This is despite a thriving startup ecosystem, high-growth companies which have made a substantial investment in setting up CoEs (centres of excellence) and the Government investing in building a robust tech infrastructure.

Behind the AI and data analytics boom, lies the story of a massive talent gap as workforce struggles to remain employable. The skills’ shelf life has shortened, with technology changing exponentially over the last decade, skills that were relevant at the beginning of the career have become obsolete. In order to remain employable, the workforce needs reskilling in India.

Reskilling in India can fill gaps

The rise of edtech companies in India is not surprising, given the huge clamour for continuous learning that has taken root in the professional sphere. This is backed by the rise of emerging technologies — Artificial Intelligence, its subset Machine Learning and Data Science which has spawned a booming job market revolving around new technologies that has substantially transformed India’s IT labour market.

The changing job economy has resulted in new opportunities for the Indian workforce. As estimated by a consulting major,

AI has the potential to add 15% of India’s current gross value in 2035. The booming economy, fuelled by AI and advanced analytics requires more Indians to enter the workforce with a different skill-set. As per estimates, close to 97,000 AI positions lie vacant in India.

However, the challenges are also increasing multifold — on the one hand Indian companies are struggling with disruptions like automation that are redefining jobs and secondly, it is grappling with finding the right talent with the right skillset for AI/ machine learning and data science teams. Meanwhile, the upcoming generation that will enter the workforce soon is fed on an outdated curriculum that hasn’t kept up with the industry’s demands.

What can key players do?

In order to capitalise on these opportunities, IT companies, educators and policymakers need to develop a deeper understanding of the existing workforce, the skill-set required in the future, and the gaps that will need to be addressed. This implies that these three key players need to align the broader economic developer agenda with the shifting job market and work towards building a strong talent that has the baseline and digital skills required for current landscape.

The government’s involvement in reskilling in India is a must. A joint report by industry body NASSCOM and FICCI level says that the IT workforce will become obsolete without government involvement. Policy makers will have to assess secondary and postsecondary education and align it with the skills that are required for tomorrow. Many leading Indian IT majors have undertaken employer-training initiatives, pre-employment training and have also provided their own courseware.

Collectively, the key stakeholders can foster a workforce development ecosystem and provide domain specific training

with a job-first approach. Given this scenario — educational stakeholders have made a very strong business case for reskilling in India and have actively partnered with renowned educational institutions to launch technical certifications and degree programmes tailored to fill the skill gap.

Source: https://thecsrjournal.in/tech-reskilling-india/

Empower Clinics $CBDT.ca Announces Advancement of Joint Venture with Heritage Cannabis in the United States $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 8:24 AM on Thursday, March 5th, 2020
  • Announced the advancement of its previously announced Joint Venture Partnership with Heritage Cannabis Holdings Corp. (CSE: CANN), based in Sandy, Oregon, USA.
  • Now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon,
  • Will immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States

VANCOUVER, BC / March 5, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company is pleased to announce the advancement of its previously announced Joint Venture Partnership (“JV”) with Heritage Cannabis Holdings Corp. (CSE: CANN) (“Heritage”), based in Sandy, Oregon, USA.

In September 2019, Empower announced it had entered into a Letter of Intent (“LOI”) to form a 50/50 ownership JV with Heritage for the extraction of hemp for CBD oil production, and formulated CBD products. The JV is equally funded by both parties and since formation CDN$250,000 has been provided to the JV.

Heritage and Empower are now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon, in order to immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States.

The proprietary branded products will be distributed through Empower’s corporately owned physician staffed health clinics in Oregon and Arizona, online at www.sunvalleyhealth.com and in upcoming new franchise locations, which currently have access to over 165,000 patients.

Additionally, related downstream equipment is now being installed including gel cap processing, tincture bottle and vape cartridge filling, as well as labelling, packaging, storage and shipping services, to offer full-service end-to-end products to third parties.

Heritage is providing training and supervision related to the proprietary methods of extraction and oil production that is already being successfully produced in Canada by Heritage.

“Having the backing of an experienced partner with the financial strength of Heritage Cannabis is proving to be so beneficial for the development of our first extraction facility”, said Steven McAuley, Chief Executive Officer of Empower. “Together, we have already identified numerous opportunities to bring new orders to the JV facility, ensuring we leverage the capacity we are building.”

“We are very pleased to be advancing our U.S. strategy through this mutually beneficial partnership with Empower, which provides Heritage ease of access to the world’s largest cannabis market”, stated Clint Sharples, Chief Executive Officer of Heritage. “The installation of extraction units is the next phase of the JV and another step toward successfully furthering our growth strategies.”

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

About Heritage Cannabis Holdings Corp.

The Company is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Education Is the New Healthcare, and Other Trends Shaping #Edtech Investing – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 12:45 PM on Wednesday, March 4th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Education Is the New Healthcare, and Other Trends Shaping Edtech Investing

By John Rogers

  • Private equity and venture funds have invested record sums into the global education sector—$30 billion in the past five years across K-12 and workplace learning
  • Since 2017, investment has accelerated with $14 billion allocated, according to research firm HolonIQ.

Despite the influx of capital, employers, schools and policymakers are only just beginning to harness the sector’s advancements in the delivery, accessibility and effectiveness of education technology. As adoption of these products and services increases around the world, so too does the opportunity for investors and entrepreneurs to generate positive social and economic impact alongside financial returns.

Here are five key trends to consider as education enters a new decade:

1. In the workplace, education is the new healthcare.

In the 1940’s and ‘50s, employers seeking to attract the best workers offered healthcare benefits. In the early 2000’s, employers offered free snacks and installed foosball tables.

Those perks have lost their luster, and with help from the Affordable Care Act, even healthcare is becoming less of a differentiator. Today, leading corporations hope to drive employee engagement, retention and advancement through providing education.

In 2014, Starbucks and Arizona State University pioneered a new kind of partnership. By offering high-quality, affordable online courses and programs, coupled with tuition assistance, ASU and Starbucks enabled thousands to become degree holders—debt free. In a recent interview with CNBC, Starbuck’s CEO Kevin Johnson pointed to the College Achievement Plan as a driver for sales growth, because employee engagement yields customer engagement.

To broaden this workplace education initiative, The Rise Fund partnered with ASU and other leading online universities to launch InStride, providing valuable educational credentials to the employees of forward-thinking corporations. In bringing affordable education to the workplace, companies like InStride, Guild, Degreed and EdAssist are addressing the biggest issues in higher education: career relevance and student debt.

2. Our schools are facing a mental health crisis.

Today, 95 percent of teenagers have access to a smartphone, and the average teen is now spending more than 7 hours per day on their screens, including over 1.5 hours on social media. But the proliferation of technology does not come without concerns. These tools can amplify feelings of loneliness and serve as a platform for cyberbullying.

Mental health problems, especially among teens, increased significantly in the last decade. Seventy percent of teenagers identify mental health as a major issue, worse than drug addiction, and gangs. Suicide is now the second-leading cause of death among 10- to 24-year-olds, and the rate has tripled over the last 10 years. In a Harvard Medical School study of 67,000 college students across more than 100 institutions, 1 out of 5 students surveyed said that they had thought about suicide.

“Teachers and administrators are hungry for effective ways to teach social and emotional learning,” says former U.S. Secretary of Education Arne Duncan.

Who will pay for these needed services? Most are paid by schools or districts, but other funding approaches are emerging. One of our portfolio investments, EverFi, finds corporate partners to fund their bullying prevention programs in schools. Other companies, like Presence Learning, are experimenting with models that may be reimbursed by health insurance, while Aperture Education helps schools to find grant funding for their services.

3. Schools spent a decade buying technology. Now they want it to work.

Education technology reached a tipping point in the last decade. Broadband penetration in K-12 schools reached over 98 percent, while low-cost computing devices like Chromebooks have proliferated in classrooms.

This has laid the infrastructure to support new instructional tools, many built by new companies that have emerged to compete with traditional print publishers. HolonIQ estimates that global spending on digital education tools surpassed $150 billion last year, and will double by 2025.

But purchasing is not proof that something works. Even more concerning: many tools may simply be gathering (digital) dust. A recent study by the University of Pennsylvania, only 30 percent of edtech licenses are actually used.

In any future economic downturn, expect technology providers who fail to show evidence of improvement—let alone usage—to get axed. Those seeking to avoid this fate would do well to invest in proving that their products work. DreamBox, (another portfolio company) invests in efficacy research led by independent third-parties including Harvard and SRI International. Lexia Learning, a subsidiary of Rosetta Stone, employs a team of PhDs who send their research out for peer review.

Recently updated federal guidelines have also raised the bar for efficacy evidence that educational services should demonstrate before public funds can be used to purchase them.

4. There is growing international demand for English-language learning.

Duolingo made headlines in December when it raised $30 million at a $1.5 billion valuation, reaching the “unicorn” milestone just seven years after the company launched. While it offers courses in several languages, a big growth driver internationally is English language learning, where it competes with online providers Babbel, Busuu and Rosetta Stone.

As businesses have expanded globally through tech and business process outsourcing, English language proficiency has become an important path to economic opportunity. According to studies by the World Bank, in India, those fluent in English earn 34 percent more on average than those who are non-fluent, while in Nigeria, the English-language wage premium is 40 percent.

In emerging markets, English language proficiency is a core component of what many parents look for as they seek high-quality schools for their children. That demand has fueled the growth of multi-billion dollar, dual-language K-12 platforms like Cognita, GEMS and Nord Anglia in markets around the world.

5. Will edtech be caught up in a backlash against ‘big tech’ over data privacy?

Rising edtech expenditures and privacy concerns have caught the eye of regulators. A group of U.S. Senators recently requested 50 technology companies—including education technology providers—to provide written responses to questions about student privacy safeguards. These inquiries come at a time when many believe the enforcement of federal education regulation is increasingly lax.

Edtech providers are as vulnerable as their peers in other industries. At a major cybersecurity conference last fall, an 18-year-old student detailed vulnerabilities he found in Blackboard, one of the most widely-used learning management systems in the country.

As U.S. edtech companies expand globally, they will also find themselves subject to stricter European data privacy laws, like GDPR. They may also find themselves at the mercy of sudden changes in national policies, such as the restrictions recently imposed in China on foreign investment in K-12 programs.

2020 and Beyond

The Rise Fund has made investments across these themes, and as we enter the next decade, the correlation between educational attainment and economic opportunity will continue to drive the demand for tools and services that bridge these two goals. For investors and entrepreneurs who choose wisely, opportunities abound for attractive returns and impact through the power of education.

Source: https://www.edsurge.com/news/2020-02-28-education-is-the-new-healthcare-and-other-trends-shaping-edtech-investing

North Bud Farms $NBUD.ca Signs Letter of Intent to Enter into Lease and Master Operations Agreement for the Cultivation Facilities at its California Farm $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:12 AM on Wednesday, March 4th, 2020
  • Signed a letter of intent for a master lease and operations agreement with an experienced California-licensed operator to operate the cultivation facilities at the Company’s Salinas, California farm
  • Cultivator will lease the Company’s cultivation facilities at its Salinas farm for 5 years, with options to extend the lease for up to an additional 5 years

Bonfire Brands USA will receive the following consideration:

  • Lease payments starting at approximately USD$1 million per year in year 1, with incremental increases that could bring the annual rent to as high as USD$1.8 million per year;
  • A royalty equal to 3% of the gross revenue generated by the Cultivator from its use of the Salinas farm; and
  • The right to acquire up to 15% of all the product harvested by the Cultivator on the farm at a discount to market rate with extended payment terms.

TORONTO, March 04, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its U.S. subsidiary, Bonfire Brands USA Inc., has signed a letter of intent (the “LOI”) for a master lease and operations agreement with an experienced California-licensed operator (the “Cultivator”) to operate the cultivation facilities at the Company’s Salinas, California farm.

Terms of the LOI

As per the terms of the LOI, the companies will work together towards completing a definitive agreement before May 1, 2020, in which the Cultivator will lease the Company’s cultivation facilities at its Salinas farm for 5 years, with options to extend the lease for up to an additional 5 years, and Bonfire Brands USA will receive the following consideration:

  • Lease payments starting at approximately USD$1 million per year in year 1, with incremental increases that could bring the annual rent to as high as USD$1.8 million per year;
  • A royalty equal to 3% of the gross revenue generated by the Cultivator from its use of the Salinas farm; and
  • The right to acquire up to 15% of all the product harvested by the Cultivator on the farm at a discount to market rate with extended payment terms.

During the term of the proposed agreement, the Cultivator will be responsible for 100% of the costs associated with staffing, operations, licensing and compliance with respect to the farm’s cultivation facilities; moreover, the Cultivator is committed to fund and manage the build-out of an additional 230,000 sq. ft. of licensed cultivation space over the first 24 months of the proposed agreement.

“Our objective when we acquired the Salinas farm was to secure access to the high-quality, low-cost cannabis that has always been grown in that area, known as “the salad bowl of America,” said Justin Braune, President of Bonfire Brands USA. “This proposed agreement will allow the Company to immediately achieve EBITDA-positive operations at our largest facility without incurring the significant capital investments that have debilitated many companies in our industry. By retaining preferential purchasing terms, the Company can focus on its branded product distribution business on the back of the estimated 40,000 pounds of production capacity that the Cultivator will bring online over the next 24 months.”

Sean Homuth, NORTHBUD’s CEO added: “Partnering with a proven licensed cultivator who has been operating in Salinas for multiple years achieves the following objectives: it significantly de-risks our California operations while allowing the Company to increase its asset value; it reduces our capital expenditure requirements while still generating significant revenue; and it builds EBITDA-positive operations without limiting our access to a cost-efficient and reliable supply chain on which to build our branded product portfolio within the state of California.”                       

About North Bud Farms Inc.

NORTHBUD, through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space, and also has active distribution and processing licenses. The Reno, Nevada property contains a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation, and holds medical and adult-use licenses for cultivation, extraction and distribution.  Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company is pursuing a license under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, those regarding the closing of the definitive agreement with the Cultivator, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Empower Clinics $CBDT.ca Announces Significant Patient Growth in February 2020 with Visits Increasing by 800% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:02 AM on Wednesday, March 4th, 2020
  • Patient visits in corporate clinics increased by 800% in February 2020 versus the same period in 2019
  • Total patient visits of 1,817 in February 2020 compared to 227 in February 2019

VANCOUVER, BC / March 4, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company, is pleased to announce that patient visits in corporate clinics increased by 800% in February 2020 versus the same period in 2019, with total patient visits of 1,817 in February 2020 compared to 227 in February 2019.

“Patient volumes have remained strong to start the year in all clinics, continuing on our push for a record first quarter.” said Dustin Klein, SVP Business Development and Director of Empower. “Operational excellence each day, combined with exemplary care for the patient, sets us apart in the markets we serve.”

The Company also has received numerous inquiries with both positive and supportive sentiment, after the recent announcement of the Company’s intention to create a psilocybin and psychedelics division.

“Getting positive reinforcement from researchers, physicians, advocates and practitioners about our intention to enter this developing field of study, gives me confidence that we have made the correct decision to leverage our corporate assets for psilocybin and psychedelics research and development.” said Steven McAuley, Chairman & CEO of Empower.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

As exit scene evolves, Indian #Edtech startups find local buyers – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 4:21 PM on Tuesday, March 3rd, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

As exit scene evolves, Indian tech startups find local buyers

  • Exits often happen at an early stage for small, undisclosed sums
  • Exits are important for the startup ecosystem because investors get returns and VC money can flow back to support new entrepreneurs

By: Malavika Velayanikal

BENGALURU : Funding, product-market fit, growth hacks, being agile, scaling—entrepreneurs obsess about all these and more when they start up. Exits are far from their thoughts, till they suddenly find themselves in a situation where they’re scrambling to get their books in order for an acquisition. It’s best to have an open mind, even if one can’t predict how a startup will fare.

Big deals like Walmart’s $16 billion acquisition of Flipkart in 2018 are as rare as the Comet Halley. Last year’s biggest acquisition was of Yatra by Ebix for $338 million. Most deals are much smaller. Data tracker Tracxn puts the median value of startup acquisitions last year at $20 million, taking into account only the ones where the acquisition price was disclosed.

Exits often happen at an early stage for small, undisclosed sums. CB Insights research shows nearly half of all exits last year were of startups that hadn’t gone beyond seed or series A funding.

Reasons to exit vary. For some, it’s an opportunity to take the money on the table for founders, employees and investors, while placing the innovation in an environment where it can go mainstream and grow bigger. For others, it may just be a better outcome than the startup shutting down or becoming a zombie. Some are acqui-hires, where a startup is acquired for its tech talent rather than a product or service.

“If you’re not able to build a business as a standalone profitable organization or attract the kind of capital needed for a venture funded business, there’s no shame in exploring opportunities in mergers and acquisitions,” says Rohan Malhotra, partner at Good Capital. “Often a missing piece that a small company provides is just what a large company has been looking for and is often beneficial for all the shareholders across the transaction.”

MAKING MONEY FLOW

Exits are important for the startup ecosystem because investors get returns and VC money can flow back to support new entrepreneurs. The Flipkart deal did a lot in that respect, but mid-sized deals are just as vital as outliers.

Many of these represent strategic business acquisition or consolidation. For example, last month Bengaluru-based digital payments startup Instamojo acquired Gurugram’s SaaS startup GetMeAShop, which helps kirana stores get online. One of the significant inbound deals last year was Cisco’s acquisition of Bengaluru-based customer analytics startup CloudCherry, which had raised $16 million in seed and series A funding.

Reliance Industries has taken the lead in corporate acquisitions of startups. Fashion etailer Fynd, website creator Nowfloats, hyperlocal restaurant delivery service Grab, fluid dynamics software maker Sankhyasutra Labs and drone maker Asteria were among its acquisitions last year. Also, an edtech startup it had acquired earlier, Embibe, merged with personalized digital learning app Funtoot. Reliance Jio also acquired Haptik for its AI virtual assistants.

Apart from mergers and acquisitions, early stage investors also get exits from follow-on funding rounds when larger VCs come in. “Investors need liquidity which often comes from secondary transactions,” says Neha Singh, co-founder of Tracxn.

SoftBank’s mega investments in India, starting in 2014, moved the needle the most, preceded by US’ Tiger Global. But the WeWork implosion has put SoftBank on the back foot as it had to write off $4.6 billion from its investment in the office space company. This has put a spanner in the works of late stage deals in recent times, although Indian startups raised a record $14.5 billion last year, according to Tracxn. That’s more than three times the $4.3 billion invested in the slowdown year of 2016, which followed the exuberance of the previous two years.

THE LOCAL CYCLE

“Like investments, exits have also improved along with the quality of entrepreneurs,” says Manish Singhal, founding partner at Pi Ventures. He cites last week’s example of customer engagement platform Freshworks acquiring AnswerIQ, which offers AI-assisted self-service. “The most interesting piece that has moved in the last couple of years is that Indian startups are buying Indian startups,” he says.

The local cycle of investment and exit would reduce dependence on external factors going forward. “What excites me is that people in India are starting to appreciate technology developed in India. That’s why local acquisitions are happening,” he says.

Singhal doesn’t worry about a large number of acquisitions being small pops rather than high value deals. “As an angel investor, if I get a small exit, I will put the money in some more companies. Anything that circulates money in a rather constipated investment scene in India is good for the ecosystem.” Source: https://www.livemint.com/companies/start-ups/as-exit-scene-evolves-indian-tech-startups-find-local-buyers-11583076229165.html

THE MOST EMOTIONAL AGORACOM INTERVIEW EVER: Green Beret Recovers From Life-Threatening #PTSD, Takes #CBD To #Military And Law Enforcement With #Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:12 AM on Tuesday, March 3rd, 2020

Adam Smith is a bad ass Green Beret with nearly 17 years of service to his country …. who put a gun in his mouth when his PTSD simply became too much to handle.  Pharma drugs prescribed by doctors were actually making his problems worse and he had nowhere to turn.    

More than just a story, watch his 2-minute video within our video interview with him and Hollister Biosciences CEO, Carl Saling.  Be prepared.  

Thankfully, a fellow soldier told him about CBD and Smith experienced firsthand how CBD can help retired and active-duty (military and law enforcement) ease their physical and mental issues – especially those who suffer from PTSD and TBI (Traumatic Brain Injury).    

The results were so dramatic that Smith’s new mission was to get CBD into the hands of as many soldiers as possible.  He founded Tactical Relief and the rest is history. Tactical Relief creates, promotes and sells the highest quality and “most patriotic” CBD oils in the country.     

Yes, it’s a great business with tremendous potential for exponential growth.  But profit isn’t driving this partnership between Smith and Carl Saling, who himself became very emotional when he shared his family’s deep military roots …. and struggles with PTSD.  

As an investor in Hollister, you’ll love what this partnership can do for the company. As a human, you’ll love what this partnership is going to do for retired and active-duty military personnel. As a host, I’ve never been more proud of two guests on AGORACOM.  

Sit back and be prepared to watch the most powerful interview ever produced by AGORACOM.    

Please share this video on your social networks so that military personnel and their families can discover Tactical Relief.  

George

Indian VC industry sees record $10 billion investment in 2019 #Edtech SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 2:43 PM on Monday, March 2nd, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Indian VC industry sees record $10 billion investment in 2019: Report

The amount was 55 per cent higher than the money invested by the industry in 2018, the report by Bain & Company’s India Venture Capital Report 2020 said. At the current exchange rate, USD 10 billion translates to over Rs 72,000 crore.

  • VC exit momentum in 2019 was in line with 2018, with secondary sales leading the mode of exits in India with an average exit value of around USD 39 million

The Indian venture capital industry invested record USD 10 billion in 2019, driven by increased deal volume and larger average deal sizes, according to a report. The amount was 55 per cent higher than the money invested by the industry in 2018, the report by Bain & Company’s India Venture Capital Report 2020 said. At the current exchange rate, USD 10 billion translates to over Rs 72,000 crore.

The report, in partnership with Indian Private Equity & Venture Capital Association (IVCA), said there has been 30 per cent increase in deal volume and 20 per cent rise in average deal size in 2019 over the previous year. “Despite substantial capital deployment, dry powder availability for VC investing in India was at an all-time high of USD 7 billion at the end of 2019, indicating likely continued investment activity in 2020,” it added.

The term ‘dry powder’ refers to cash reserves kept on hand by a company, venture capital firm or individual to cover future obligations. The VC exit momentum in 2019 was in line with 2018, with secondary sales leading the mode of exits in India with an average exit value of around USD 39 million. “Despite the global economic climate, India’s startup and VC ecosystems continue to thrive as investors take a long- term view based on the country’s growth potential. We go into 2020 with record-high levels of dry powder, counter-balanced with caution and an underlying optimism in the long-term potential for the ecosystem,” Arpan Sheth, Partner at Bain & Company, said.

About 80 per cent of the VC investments in 2019 was concentrated in four sectors — consumer tech, software/ SaaS, fintech and B2B commerce and tech. Consumer tech continued to be the largest sector, accounting for approximately 35 per cent of the total investments with several scale deals exceeding USD 150 million, the report said. Within consumer tech, verticalised e-commerce companies continued to be the largest sub-segment. In addition, there were increased investments in healthtech, foodtech and edtech as well.

“The Indian VC industry had a landmark year in 2019. However, India-focused VC investments raised less funds this year, the fundraising outlook for 2020 remains positive among both LPs and GPs (Limited Partners and General Partners),” Sriwatsan Krishnan, Partner at Bain & Company and co-author of the report, said. Following the brief moderation between 2015 and 2017, the VC industry in India has been in a renewed growth phase and that is expected to continue, Krishnan added.

The Indian startup ecosystem, one of the top five globally, continued to remain robust and grow rapidly. Between 2012 and 2019, the number of startups in India increased 17 per cent each year, while funded startups increased faster at 19 per cent CAGR in the same period, the report said. Currently, of almost 80,000 startups in India, only about 8 per cent are funded, indicating room for investments, it added. The report said India-focused VC funds raised about USD 2.1 billion in 2019, slightly lower than that in 2018.

The dip was the result of marquee funds that had already raised large sums and hence did not go to the market in 2019, it added. “There is a massive pipeline of soon to be unicorns; few of the Indian Unicorns will become decacorns by 2025. All this could not have happened without the support of the current government and the exits driven by first-generation entrepreneurs in the last couple of years,” IVCA President Rajat Tandon said.

Source: https://www.financialexpress.com/market/indian-vc-industry-sees-record-10-billion-investment-in-2019-report/1886543/

CLIENT FEATURE: Hollister Biosciences $HOLL.ca – Signed $20M LOI To Acquire Venom Extracts With $16.4M CAD In 2019 Revenue and 2.48M CAD in EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 9:00 PM on Thursday, February 27th, 2020
HOLL:CSE /HOB:FRA

BREAKING: Signed $20,000,000 Letter of Intent To Acquire Venom Extracts (“Venom”)

HIGHLY ACCRETIVE $20,000,000 ACQUISITION

Venom Highlights

  • 2019 Est Revenue ~C$16.4M; EBITDA ~C$2.48M
  • 30% Of Acquisition Price Paid If Venom Revenues Hit $30,000,000 and $40,000,000 By DEC 31, 2021
  • Average revenue per gram YTD 2019 $CDN 14 and will continue to increase as vape cartridge mix grows ($CDN 30 per gram)
  • One Of Arizona’s Largest Producers Of Award-Winning Medical Cannabis Distillate
  • Acquisition Expected To Close By March 31, 2020 Subject To Due Diligence

An established brand in Arizona for high quality products in the wholesale and distillate marketplace. Venom is leveraging its brand and success to aggressively expand into other US states.

ACQUISITION TERMS

  • Hollister will acquire Venom Extracts for CDN$20,000,000 via Hollister stock
  • The stock price will be determined based on the greater of:
    • The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
    • Once share price is established, 70% of the Payment Shares will be issued upon closing of the transaction
    • Remaining 30% of the Payment Shares will be issued when and if the following milestones have been met on or prior to December 31st, 2021

Per State Cash Flow Expectations

Planned State Additions

FIND OUT MORE!

Hub On AGORACOM / Corporate Profile / Read Release

FULL DISCLOSURE: Hollister Biosciences Inc. is an advertising client of AGORA Internet Relations Corp.

Empower Clinics $CBDT.ca – CBD consumption to rise across the treatment of neurological conditions $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 1:53 PM on Thursday, February 27th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

CBD consumption to rise across the treatment of neurological conditions

Research shows that CBD consumption for the treatment of neurological conditions is set to rise.

  • With an exponential rise in the availability of CBD products and public opinion towards it becoming more positive over the past decade, the consumption of the ingredient has exploded.
  • Global Market Insights, Inc., forecasts that global cannabidiol market size will be worth more than $89bn by 2026.

By: Health Europa

However, the industry will need to overcome the complex regulatory landscape as well as quality and supply challenges in the near future.

Over the past few years, cannabidiol, or CBD, has caught the public’s imagination as an ingredient presenting a range of health benefits when infused in various consumables. More and more individuals worldwide are now vouching for its effectiveness in terms of alleviating certain chronic illnesses and treating several health conditions.

CBD has conquered industry after industry, from pharmaceuticals to personal care and cosmetics, food and beverages, and nutraceuticals.

Cannabidiol is the legal and non-psychoactive counterpart of tetrahydro cannabidiol (THC), the chemical compound responsible for cannabis’s psychological effects. CBD is the second most-commonly used active ingredients of cannabis. The cannabinoid is derived directly from the hemp plant, a cousin of the cannabis plant, and forms an essential component of medical cannabis.

CBD regulatory landscape in Europe

Factors such as population growth, nationalised healthcare, GDP, and cultural historic use of CBD in many European countries make the continent an attractive market for global producers of both medical and retail cannabis-based products. Hemp cultivation in the region has witnessed a massive upsurge in recent years; the European Union (EU) constitutes more than 25% of the global hemp production.

In July last year Epidiolex CBD oil received a positive recommendation for marketing approval from the European Medicines Agency (EMA) for the treatment of seizures. EMA’s Human Medicines Committee (CHMP) approved the oral solution for use with clobazam for the treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in patients aged two or more.

The European Commission granted marketing approval to Epidyolex, the trade name for Epidiolex in Europe, in September 2019. Epidiolex is the only federally-approved CBD product in the U.S.

Additionally, the use of CBD in cosmetics is harmonised within the European Cosmetic Regulation 1223/2009. The regulation prohibits the use of cannabis and its derivatives in cosmetic products. Essentially, EU prohibits the use of CBD derived naturally from cannabis plants. However, the use of hemp-derived or synthetically-produced cannabidiol is approved.

Europe CBD market is poised to witness monumental growth in the forthcoming years on account of surging consumer demand for safe-strength CBD products that are easily available in their normal retail environments and cultivated, extracted, processed and labelled as per the European standards.

Growing burden of neurological diseases in Europe

Europe has witnessed a growing occurrence of various neurological conditions in recent years. These include epilepsy, migraine, stress, anxiety, and numerous sleeping disorders. An expanding geriatric population base indicates rising incidences of these conditions. Citing data from the European Brain Council, more than 220 million people in Europe suffer from at least one neurological condition, which is more than the populations of France, Germany, and the Great Britain combined.

Described below are some of the most prevalent neurological conditions in Europe and the effectiveness of CBD in their treatment.

  • Stress and anxiety – Nearly 25% of the European population suffers from stress, anxiety or depression each year. The effectiveness of CBD products as anti-anxiety nutraceuticals is backed with plenty of research, however there is still a long way to go. Several clinical trials have provided considerable evidence of cannabidiol’s usefulness for the treatment of generalised anxiety disorder (GAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), social anxiety disorder, and panic disorder;
  • Migraine – Migraine currently affects more than 11% of the global population. The social societal burden of migraine in Europe is an approximately €27bn per year. While pain medications are known to help temporarily alleviate the symptoms of migraine, they can have several side-effects. Research concerning the use of cannabidiol for migraine is limited however a number of laboratory studies suggest that CBD oil may help reduce all types of acute and chronic pain, including migraine; and
  • Seizures – In Europe, close to six. million people suffer from epilepsy, while 15 million people will have at least one seizure at some point during their lifetime. Numerous research studies over the years have demonstrated the benefits and effectiveness of hemp-derived CBD products in patients with epilepsy who have not responded to traditional treatment.

Surging popularity of cannabidiol among boomers along with ongoing research and development into its potential health benefits will augment CBD market forecast. More and more boomers are adding CBD to their health regimes to help reduce stress and anxiety, get better sleep, and alleviate chronic pain. Increasing awareness towards the safety and efficacy of cannabidiol products will drive future CBD industry trends.

Source: https://www.healtheuropa.eu/cbd-consumption-to-rise-across-the-treatment-of-neurological-conditions/98105/